Upgrade to see committee overlap, performance context, and full expert analysis.
ALB congressional trades
7 matched disclosures
ALB congressional trades snapshot
This page summarizes public STOCK Act disclosures involving ALB. It is useful for seeing which lawmakers reported ALB transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Jun 16, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
What the ALB congressional trade page shows
Congressional Trader tracks 7 public STOCK Act disclosures for ALBacross 4 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent ALB filing shown here was filed on Jun 16, 2026 by John Boozman as a purchase. Related lawmakers include Jefferson Shreve, Rick W. Allen, John Boozman, Julie Johnson.
Top lawmakers for ALB
Pro performance summary
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansUpgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
FAQ
Which lawmakers traded ALB?
Recent ALB disclosures include Jefferson Shreve, Rick W. Allen, John Boozman, Julie Johnson.
What is the buy/sell mix for ALB?
The visible sample currently shows 2 purchases and 5 sales or partial sales.
Should I trade based on ALB disclosures?
No. This page summarizes public filings for research and monitoring. It is not investment advice.